An Van den Bergh

1.5k citations

30 papers · 960 indexed · h-index 15

Co-authors: Paul Herijgers Willem Flameng Erik Verbeken Sofie Janssen Karen Maes Marc Decramer Ghislaine Gayan‐Ramirez Jan D’hooge
Topics: Cardiovascular Function and Risk Factors (8 papers)Cardiac electrophysiology and arrhythmias (6 papers)Pharmacogenetics and Drug Metabolism (5 papers)
Cited by: Cardiology and Cardiovascular Medicine Sensory Systems Pharmaceutical Science
Journals: Circulation Journal of Clinical Investigation Journal of Medicinal Chemistry
Partner nations: Belgium United States Germany

In The Last Decade

An Van den Bergh

30 papers receiving 941 citations

Peers

Countries citing papers authored by An Van den Bergh

Since Specialization

Citations

This map shows the geographic impact of An Van den Bergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Van den Bergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Van den Bergh more than expected).

Fields of papers citing papers by An Van den Bergh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An Van den Bergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Van den Bergh. The network helps show where An Van den Bergh may publish in the future.

Co-authorship network of co-authors of An Van den Bergh

This figure shows the co-authorship network connecting the top 25 collaborators of An Van den Bergh. A scholar is included among the top collaborators of An Van den Bergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Van den Bergh. An Van den Bergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human organotypic colon in vitro microtissue: unveiling a new window into colonic drug disposition 2025 ·European Journal of Pharmaceutical Sciences ·(unknown),Jan Snoeys,(unknown),Marjolein van Heerden,An Van den Bergh,(unknown),Ján Markus,Seyoum Ayehunie,Mario Monshouwer,Raymond Evers,Patrick Augustijns,Stephanie Schulz	2
2	Toward Dose Prediction at Point of Design 2024 ·Journal of Medicinal Chemistry ·Dries Van Rompaey,(unknown),Mazen Ahmad,Justin S. Cisar,An Van den Bergh,Jeremy R. Ash,Zhe Wu,Marian C. Bryan,James P. Edwards,Renée L. DesJarlais,Jörg K. Wegner,Hugo Ceulemans,Kaushik Mitra,David Polidori	5
3	Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model 2020 ·Clinical Pharmacokinetics ·An Van den Bergh,Jan Snoeys,Loeckie De Zwart,Peter Ward,Angela Lopez‐Gitlitz,Danièle Ouellet,Mario Monshouwer,Caly Chien	16
4	PBPK Absorption Modeling: Establishing the In Vitro–In Vivo Link—Industry Perspective 2019 ·The AAPS Journal ·Cordula Stillhart,Xavier Pépin,Christophe Tistaert,David Good,An Van den Bergh,Neil Parrott,Filippos Kesisoglou	62
5	In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopharmaceutical development 2019 ·European Journal of Pharmaceutics and Biopharmaceutics ·Patricia Zane,Hille Gieschen,(unknown),Neil Mathias,Céline Ollier,(unknown),An Van den Bergh,(unknown),Andreas Reichel,(unknown),Kerstin Schäfer,Anette Müllertz,Peter Langguth	19
6	NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, but Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight Loss 2013 ·Journal of Vascular Research ·Ines Nevelsteen,An Van den Bergh,Gerry Van der Mieren,Annelies Vanderper,Kanigula Mubagwa,Hidde Bult,Paul Herijgers	19
7	ACE-inhibition, but not weight reduction restores cardiomyocyte response to β-adrenergic stimulation in the metabolic syndrome 2013 ·BMC Cardiovascular Disorders ·Ines Nevelsteen,Virginie Bito,Gerry Van der Mieren,Annelies Vanderper,An Van den Bergh,Karin R. Sipido,Kanigula Mubagwa,Paul Herijgers	10
8	Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data 2011 ·Clinical Pharmacokinetics ·An Van den Bergh,Vikash Sinha,Ron Gilissen,Roel Straetemans,(unknown),Denise Morrison,Luc Bijnens,Claire Mackie	23
9	Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice 2010 ·Journal of Clinical Investigation ·Ilka Mathar,Rudi Vennekens,Marcel Meissner,Frieder Kees,Gerry Van der Mieren,Juan E. Camacho Londoño,(unknown),Thomas Voets,Björn Hummel,An Van den Bergh,Paul Herijgers,Bernd Nilius,Veit Flockerzi,Frank Schweda,Marc Freichel	127
10	Food-Restriction in Obese Dyslipidaemic Diabetic Mice Partially Restores Basal Contractility but not Contractile Reserve 2009 ·European Journal of Heart Failure ·An Van den Bergh,Peter Vangheluwe,Annelies Vanderper,Peter Carmeliet,Frank Wuytack,Stefan Janssens,Willem Flameng,Paul Holvoet,Paul Herijgers	12
11	Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance 2008 ·European Heart Journal ·Gunnar Buyse,Gerry Van der Mieren,Michael A. Erb,Jan D’hooge,Paul Herijgers,Eric Verbeken,Alejandro Jara,An Van den Bergh,Luc Mertens,I. Courdier-Fruh,Patrizia Barzaghi,Thomas Meier	82
12	Influence of Heart Rate Reduction on Doppler Myocardial Imaging Parameters in a Small Animal Model 2008 ·Ultrasound in Medicine & Biology ·Caroline Weytjens,Jan D’hooge,Steven Droogmans,An Van den Bergh,Bernard Cosyns,Tony Lahoutte,Paul Herijgers,Guy Van Camp	11
13	Apoptosis levels of CD34+cells after induced DNA damage: Measurement of DNA fragmentation in different annexin V-affinity fractions of sorted CD34+cells using the DNA diffusion assay and comet assay 2007 ·Acta Clinica Belgica ·(unknown),Luc Raeymaekers,An Van den Bergh,(unknown),Marc Boogaerts,Michel Delforge	1
14	Cardiomyocyte-specific overexpression of type 5 phosphodiesterase impairs postinfarction myocardial function and left ventricular remodeling 2007 ·Circulation ·Péter Pokreisz,Marijke Pellens,An Van den Bergh,Hilde Gillijns,Virginie Bito,(unknown),Liesbeth Biesmans,Glenn Marsboom,Pieter Vermeersch,Jan D’hooge,Karin R. Sipido,Paul Herijgers,Luc Schoonjans,Kenneth D. Bloch,Stefan Janssens	4
15	Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness 2007 ·Cardiovascular Research ·An Van den Bergh,Annelies Vanderper,Peter Vangheluwe,Fanny Desjardins,Ines Nevelsteen,Wim Verreth,Frank Wuytack,Paul Holvoet,Willem Flameng,Jean‐Luc Balligand,Paul Herijgers	64
16	Parameters of ventricular contractility in mice: influence of load and sensitivity to changes in inotropic state 2007 ·Pflügers Archiv - European Journal of Physiology ·An Van den Bergh,Willem Flameng,Paul Herijgers	32
17	A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span 2006 ·Journal of Molecular and Cellular Cardiology ·Peter Vangheluwe,Marc Tjwa,An Van den Bergh,William E. Louch,Monique Beullens,Leonard Dode,Peter Carmeliet,Evangelia G. Kranias,Paul Herijgers,Karin R. Sipido,Luc Raeymaekers,Frank Wuytack	45
18	Type II Diabetic Mice Exhibit Contractile Dysfunction but Maintain Cardiac Output by Favourable Loading Conditions 2006 ·European Journal of Heart Failure ·An Van den Bergh,Willem Flameng,Paul Herijgers	53
19	The examination of the reliability and validity of the LASSI for the assessment of developing students' learning and study strategies in the RSA 1998 ·South African Journal of Higher Education ·An Van den Bergh,(unknown)	3
20	DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain - suggesting an apoptotic cell death 1995 ·British Journal of Cancer ·Christina Vallbo,Tommy Bergenheim,An Van den Bergh,Kjell Grankvist,Roger Henriksson	22

About An Van den Bergh

An Van den Bergh is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Statistics and Probability, having authored 30 papers that have together received 960 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (8 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (439 citations), Sensory Systems (92 citations) and Pharmaceutical Science (69 citations). An Van den Bergh has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Paul Herijgers, Willem Flameng, Erik Verbeken, Sofie Janssen, Karen Maes, Marc Decramer, Ghislaine Gayan‐Ramirez, Jan D’hooge, Gerry Van der Mieren and André La Gerche. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact